Regen Report · Apr 2026
A long-form interview describing how iDEM automates adherent stem-cell workflows, the CDMO launch, and the first site at CGT Catapult’s Stevenage manufacturing center.
Company research
Public company, workplace, funding, and market signals
Updated Aug 16, 2026
Overview
Mytos is a London-based biotechnology company that automates the manufacture of stem cell-derived therapies. Its core product is the iDEM automated cell manufacturing platform, which powers both customer manufacturing collaborations and Mytos’ own automated CDMO offering.
Primary product
iDEM automated cell manufacturing platform / automated CDMO for regenerative medicine
Founded
2016
Headquarters
London, England, United Kingdom
Team size
11-50 employees
Industry
Biotechnology Research
Sub-industry
Cell manufacturing automation / regenerative medicine / cell therapy CDMO
Offices
London, United Kingdom
Stevenage, United Kingdom (CGT Catapult site for first CDMO facility)
United States (presence reported)
Norway (presence reported)
Spain (workforce distribution reported)
Business model
B2B SaaS/platform licensing
contract development and manufacturing (CDMO)
strategic collaborations / partnership-based services
Funding
Stage
Series A
Total raised
$20.9M
Latest round
Series A · Nov 2023
Latest amount
$19M
Series A
Nov 2023 · Buckley Ventures
Venture Round
Jul 2022 · TBD Angels
Seed Round
Jan 2019
People & investors
Leadership
Ali Afshar
CEO Co-Founder
Ignacio Willats
Co-Founder
Justin Chan
Head of Engineering
Felix Q.
Senior Director of Business Development
Xian Weng Jiang
Director of Product Solutions
Stephen Weston
Biology Technical Lead
Barry J. Oliver
Interim Head of Quality
David DiGiusto
Advisor
Work & culture
Public evidence suggests a science- and engineering-heavy culture focused on automation, translational biotech, and rapid scaling. Mytos’ public messaging emphasizes hiring, world-class engineers and scientists, and partnering closely with customer companies.
Product & market
Pricing
Not publicly disclosed; likely enterprise partnership and CDMO contract pricing.
Differentiators
- —Automates adherent stem cell and cell-therapy manufacturing using iDEM
- —Uses a platform intended to preserve manual flask-based workflows while improving repeatability
- —Offers both platform-enabled collaborations and an owned automated CDMO model
- —Focuses on regenerative medicine scale-up and low-cost per-dose manufacturing
Technology
iDEM robotics platform
automation/robotics
GMP manufacturing infrastructure
Customers
Aspen Neuroscience
StemSight
Rinri Therapeutics
Novadip
Pluristyx
Competitors
Cellares
Catalent
Resilience
other cell therapy CDMOs / automated cell manufacturing platforms
Scale & contact
Estimated monthly visits
6.3K
Traffic estimate as of Jun 2026
Latest news
Endpoints News · Oct 2025
Reported launch of Mytos’ first UK CDMO facility at the Cell and Gene Therapy Catapult site in Stevenage, and leadership expansion with executives from Catalent, Cellares, and Resilience.
Business Wire · Oct 2025
Announced the launch of Mytos’ automated CDMO, housed at CGT Catapult’s Stevenage site, with the goal of scaling regenerative-medicine manufacturing and lowering per-dose costs.
Pharma Manufacturing · Oct 2025
Summarized Mytos’ automated CDMO launch, target clinical readiness by September 2026, and stated capacity goals of up to 1,500 autologous or 25,000 allogeneic doses annually.
BioSpace / Business Wire · Sep 2025
Reported new manufacturing collaborations with StemSight, Rinri Therapeutics, and Novadip to use iDEM for ocular, hearing-loss, and bone-defect cell therapies.
Jobs and careers at Mytos
10 jobs at Mytos
Manufacturing Lead (Hardware)
On-site
London
2w ago
On-site
Full-time
Principal Scientist (PD/MSAT)
On-site
London
3mo ago
On-site
Full-time
Chief of Staff
On-site
London
9mo ago
On-site
Full-time
Quality (QA) Lead - CDMO
On-site
London and Stevenage
9mo ago
On-site
Full-time
Junior Mechanical Engineer (Summer 2026)
On-site
London
10mo ago
On-site
Full-time
Senior Mechanical Engineer
On-site
London
1y ago
On-site
Full-time
Junior/Mid Software Engineer
Hybrid
London
1y ago
Hybrid
Full-time
Senior Product Designer
On-site
London
2y ago
On-site
Full-time
General Opportunity
On-site
London
2y ago
On-site
Full-time
Engineering Technician
On-site
London
2y ago
On-site
Full-time